Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiotoxicity 2Breast Neoplasms 2Peripheral Nervous System Diseases 1Cognitive Dysfunction 1

Interventions

Paclitaxel 3Acupuncture Therapy 3Glutamine 2Fatty Acids, Omega-3 2Cryotherapy 2eribulin 1Yoga 1Vitamin D 1Vitamin B 6 1Vitamin B 12 1Thioctic Acid 1Taxoids 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Silymarin 1Saline Solution 1Physical Therapy Modalities 1Pentoxifylline 1Omacor 1Minocycline 1Methods 1Metformin 1Massage 1Magnetic Resonance Spectroscopy 1Losartan 1Lidocaine 1Hydroxychloroquine 1Fumigant 93 1Fish Oils 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peripheral Nervous System Diseases × Silymarin × Breast × Clear all
NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Tanta University

Phase 2/3 Unknown
56 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡